Related Experiment Videos

The effects of oxytetracycline on Theileria parva in vitro

P R Spooner1

  • 1International Laboratory for Research on Animal Diseases, Nairobi, Kenya.

Parasitology
|February 1, 1990
PubMed

Insights

Immediate oxytetracycline (OTC) treatment halts Theileria parva development in cattle. This finding explains OTC

Area of Science:

  • Veterinary Parasitology
  • Molecular Biology
  • Pharmacology

Background:

  • Theileria parva causes East Coast fever, a significant cattle disease.
  • Tetracyclines are sometimes used prophylactically but their therapeutic efficacy is limited.

Purpose of the Study:

  • To investigate the effect of oxytetracycline (OTC) on Theileria parva sporozoite development in bovine leukocytes.
  • To determine the stage-specific sensitivity of Theileria parva to OTC.

Main Methods:

  • Infection of bovine peripheral blood leukocytes with Theileria parva sporozoites.
  • Treatment with varying concentrations and durations of oxytetracycline.
  • Assessment of schizont development and host cell transformation.
  • Cytostatic effect evaluation on infected and uninfected cell lines.

Main Results:

  • Immediate OTC treatment inhibited sporozoite development to mature schizonts in a dose- and time-dependent manner.
  • Concentrations of 5 µg/ml OTC for 8 days completely prevented schizont establishment.
  • OTC exhibited a cytostatic effect on both infected and uninfected lymphoblasts.
  • Mature schizonts within host cells were not demonstrably affected by OTC.

Conclusions:

  • Oxytetracycline is effective against developing Theileria parva, explaining its prophylactic use.
  • OTC's lack of effect on established schizonts explains its therapeutic limitations in treating active East Coast fever.

Related Concept Videos